Genus (LON:GNS)‘s stock had its “buy” rating reaffirmed by Peel Hunt in a research report issued on Thursday, ThisIsMoney.Co.Uk reports.
Several other equities research analysts also recently issued reports on the company. HSBC lifted their price objective on Genus from GBX 3,000 ($39.46) to GBX 3,260 ($42.88) and gave the stock a “buy” rating in a report on Wednesday, November 13th. Jefferies Financial Group started coverage on Genus in a report on Friday, November 15th. They set a “hold” rating and a GBX 3,272 ($43.04) price objective on the stock. Liberum Capital lifted their price objective on Genus from GBX 2,800 ($36.83) to GBX 3,450 ($45.38) and gave the stock a “buy” rating in a report on Thursday, November 28th. Finally, Peel Hunt restated a “buy” rating and set a GBX 3,200 ($42.09) price objective on shares of Genus in a report on Thursday, November 14th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of GBX 3,177.83 ($41.80).
GNS stock opened at GBX 3,190 ($41.96) on Thursday. The company has a quick ratio of 1.19, a current ratio of 2.01 and a debt-to-equity ratio of 21.92. Genus has a 52-week low of GBX 2,146 ($28.23) and a 52-week high of GBX 3,358 ($44.17). The stock’s 50 day moving average is GBX 3,141.36 and its two-hundred day moving average is GBX 2,954.72. The company has a market capitalization of $2.08 billion and a PE ratio of 268.07.
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.